Feeds:
Posts
Comments

Search Results for 'CRISPR/Cas9'


Alternative to CRISPR/Cas9 – CAST (CRISPR-associated transposase) – A New Gene-editing Approach for Insertion of Large DNA Sequences into a Genome developed @BroadInstitute @MIT @Harvard Reporter: Aviva Lev-Ari, PhD, RN   A new gene-editing CAST member In Science, a team led by Jonathan Strecker, Alim Ladha, and core institute member Feng Zhang reports a new gene-editing approach that […]

Read Full Post »


Will the Supreme Court accept a UC Berkeley Appeal of the Sep. 10th, US Court of Appeals for the Federal Circuit decision to uphold the patent filed by the Broad Institute on CRISPR/Cas9 gene editing? Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on June 6, 2019 Several companies were founded on the initial CRISPR IP rights granted […]

Read Full Post »


On June 12, 2018 – Berkeley was granted a patent on using CRISPR/Cas9 to edit single-stranded RNA. On June 19, 2018 – Berkeley was granted a second patent, covering the use of CRISPR-Cas9 gene editing with formats that will be particularly useful in developing human therapeutics and improvements in food security. Reporter and Curator: Aviva Lev-Ari, PhD, RN […]

Read Full Post »


Reporter and Curator: Dr. Sudipta Saha, Ph.D.   The CRISPR-Cas9 system has proven to be a powerful tool for genome editing allowing for the precise modification of specific DNA sequences within a cell. Many efforts are currently underway to use the CRISPR-Cas9 system for the therapeutic correction of human genetic diseases. CRISPR/Cas9 has revolutionized our […]

Read Full Post »


Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing Reporter: Aviva Lev-Ari, PhD, RN [Boldface added] Appeal seeks reversal of Patent Trial and Appeal Board decision terminating interference without determining priority of inventorship of CRISPR/Cas9 gene editing Brief asserts that the Board failed to properly apply controlling U.S. Supreme Court and […]

Read Full Post »


FEBS Journal Special Issue on CRISPR/Cas9 Gene Editing by news.wiley.com Reporter: Aviva Lev-Ari, PhD, RN   FEBS Journal Special Issue on CRISPR FEBS Journal Special Issue on CRISPR/Cas9 The FEBS Journal The discovery of CRISPR in archaea and bacteria The FEBS Journal Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens The FEBS Journal […]

Read Full Post »


LIVE – The CRISPR/Cas9 Revolution and Gene Editing: 2016 WARREN ALPERT FOUNDATION PRIZE SYMPOSIUM Reporter: Aviva Lev-Ari, PhD, RN Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium hosted by Harvard Medical School. OCTOBER 6, 2016 – 1:30PM TO 5:30PM 2016 WARREN ALPERT FOUNDATION PRIZE SYMPOSIUM The CRISPR/Cas9 […]

Read Full Post »


LIVE 9/21 8AM to 10:55 AM Expoloring the Versatility of CRISPR/Cas9 at CHI’s 14th Discovery On Target, 9/19 – 9/22/2016, Westin Boston Waterfront, Boston http://www.discoveryontarget.com/ http://www.discoveryontarget.com/crispr-therapies/ Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a Media Partner of CHI for CHI’s 14th Annual Discovery on Targettaking place September 19 – 22, 2016 in Boston. In Attendance, streaming LIVE using Social Media […]

Read Full Post »


LIVE 9/19 1:40 – 3:20 EMERGING APPLICATIONS OF CRISPR/CAS9 at CHI’s 2nd Annual Symposium CRISPR: Mechanisms and Applications @ CHI’s 14th Discovery On Target, 9/19 – 9/22/2016, Westin Boston Waterfront, Boston   CHI’s 2nd Annual Symposium CRISPR: Mechanisms and Applications @ CHI’s 14th  Discovery On Target, 9/19 – 9/22/2016, Westin Boston Waterfront, Boston http://www.discoveryontarget.com/ http://www.discoveryontarget.com/crispr-therapies/ #BostonDOT16 @BostonDOT […]

Read Full Post »


LIVE 9/19 8AM – 10AM USING CRISPR/Cas9 FOR FUNCTIONAL SCREENING CHI’s 2nd Annual Symposium CRISPR: Mechanisms and Applications @CHI’s 14th Discovery On Target, 9/19 – 9/22/2016, Westin Boston Waterfront, Boston http://www.discoveryontarget.com/ http://www.discoveryontarget.com/crispr-therapies/ Meeting #: #BostonDOT16 Meeting @: @BostonDOT Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a Media Partner of CHI for CHI’s 14th Annual Discovery on Target taking […]

Read Full Post »

Next »